Mirador Capital Partners LP Purchases 646 Shares of Cardinal Health, Inc. (NYSE:CAH)

Mirador Capital Partners LP lifted its stake in Cardinal Health, Inc. (NYSE:CAH) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,854 shares of the company’s stock after acquiring an additional 646 shares during the quarter. Mirador Capital Partners LP’s holdings in Cardinal Health were worth $1,326,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Clearstead Trust LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth approximately $25,000. Raleigh Capital Management Inc. grew its stake in shares of Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after acquiring an additional 268 shares during the period. BKM Wealth Management LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth approximately $30,000. Hexagon Capital Partners LLC grew its stake in shares of Cardinal Health by 53.6% in the fourth quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock worth $34,000 after acquiring an additional 118 shares during the period. Finally, Wetzel Investment Advisors Inc. bought a new stake in shares of Cardinal Health in the fourth quarter worth approximately $36,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Trading Up 1.2 %

CAH traded up $1.22 during trading hours on Monday, hitting $99.03. The company’s stock had a trading volume of 177,299 shares, compared to its average volume of 2,202,615. The business’s 50-day moving average price is $99.88 and its 200-day moving average price is $104.48. Cardinal Health, Inc. has a 12 month low of $85.11 and a 12 month high of $116.04. The stock has a market cap of $24.12 billion, a price-to-earnings ratio of 43.70, a P/E/G ratio of 1.11 and a beta of 0.61.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.13. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The company had revenue of $54.90 billion for the quarter, compared to analysts’ expectations of $56.05 billion. During the same quarter in the previous year, the business posted $1.74 earnings per share. Cardinal Health’s quarterly revenue was up 8.7% on a year-over-year basis. On average, analysts forecast that Cardinal Health, Inc. will post 7.35 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a dividend of $0.5056 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.50. The ex-dividend date is Monday, July 1st. This represents a $2.02 dividend on an annualized basis and a yield of 2.04%. Cardinal Health’s payout ratio is 88.89%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research analyst reports. Argus reduced their price target on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. Robert W. Baird cut their target price on shares of Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research report on Friday, May 3rd. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Monday, June 24th. Evercore ISI boosted their target price on shares of Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a research report on Friday, May 3rd. Finally, Wells Fargo & Company cut their target price on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $109.67.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.